Cationic Lipid Nanoparticles Balancing Delivery and Thermal Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing lipid nanoparticles for therapeutic agent delivery, such as mRNA vaccines, face challenges with low thermal stability, limiting storage and distribution, and there is a need for novel lipid molecules to improve their stability and efficacy.
Innovation Solution
Development of novel cationic lipids formulated as nanoparticles with specific structures (I, II, and III) for encapsulating nucleic acids, providing a hydrophilic core and lipid bilayer shell for enhanced stability and delivery efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional lipid nanoparticles are used for mRNA vaccine delivery, then efficient intracellular delivery and immune response induction are achieved, but thermal stability is low limiting storage and distribution
Solution Approach 1:
The patent modifies the chemical structure of lipid molecules by introducing specific functional groups (carboxylic acid, hydroxyl, amino groups) at defined positions in the lipid backbone. These parameter changes in molecular structure enhance the thermal stability of the nanoparticle formulation while preserving the cationic charge necessary for efficient nucleic acid delivery and immune response induction.
Solution Approach 2:
The invention creates composite lipid structures combining hydrophobic regions (for membrane integration and stability) with hydrophilic functional groups (for nucleic acid interaction and stability). This composite approach allows the nanoparticle to maintain both delivery efficiency and improved thermal stability for extended storage at higher temperatures.
2Stability of the object's composition
If mRNA vaccines are stored at low temperatures (−20°C to −80°C), then thermal stability is maintained, but storage and distribution complexity increases
Solution Approach 1:
By changing the physical-chemical parameters of the lipid molecules (introducing stable functional groups and optimizing chain lengths), the nanoparticle formulation achieves enhanced thermal stability that allows storage at higher temperatures (e.g., 2°C to 25°C), thereby simplifying the cold chain infrastructure requirements for storage and distribution.
3Reliability
If novel cationic lipids with specific structures are developed, then thermal stability and delivery efficacy are enhanced, but manufacturing complexity increases
Solution Approach 1:
The lipid molecules are designed with segmented functional regions (hydrophobic tail, polar head group, and specific functional groups at defined positions) that can be synthesized through modular chemical reactions. This segmentation allows for systematic manufacturing while achieving the desired stability and efficacy properties.
Solution Approach 2:
The patent defines specific parameter ranges for lipid structures (positions of functional groups, chain lengths, molecular weights) that optimize both stability and efficacy. These defined parameters provide clear manufacturing specifications that reduce complexity by eliminating the need for extensive optimization trials.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The novel lipids enable efficient intracellular delivery of nucleic acids, achieving protein expression levels up to 100,000-folds greater than controls, and effective immune response induction for diseases like SARS-CoV-2 and dengue, with potential for extended-release formulations.
Implementation Method 1
A lipid nanoparticle encapsulates a region of aqueous solution inside a hydrophobic membrane, dissolved hydrophilic solutes cannot readily pass through the lipids
Implementation Method 2
the lipid bilayer can fuse with other bilayers such as the cell membrane, thus delivering the liposome contents inside the cell
Implementation Method 3
Hydrophobic chemicals can be dissolved into the membrane
Data Source
AI summary
Disclosed herein are novel lipids, lipid nanoparticlcs and their uses for the transport of therapeutic agents to a subject, or for the treatment and/or prophylaxis of diseases in the subject.